Clinical Trial Update: Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating selective pelvic lymphadenectomy for cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Fudan University | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN